investorscraft@gmail.com

Stock Analysis & ValuationImmunovia AB (publ) (0G8X.L)

Professional Stock Screener
Previous Close
£0.19
Sector Valuation Confidence Level
High
Valuation methodValue, £Upside, %
Artificial intelligence (AI)0.207
Intrinsic value (DCF)0.08-57
Graham-Dodd Methodn/a
Graham Formula0.60222

Company Information

Medicon Village
Lund 223 63
SE
Phone: 46 4 62 75 60 00
Industry: Medical - Diagnostics & Research
Sector: Healthcare
CEO: Jeff Borcherding
Full Time Employees: 9

Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

HomeMenuAccount